Diflunisal Tablet, Film Coated
Product Images NDC 0093-9222

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diflunisal (NDC 0093-9222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Diflunisal (Image 1)

FDA Label Image

Rev. F 7/2015 (Image 2)

FDA Label Image

1 (Image 3)

1 (Image 3)
This text describes the composition, dosage, and manufacturer information for a medication containing 500mg of diflunisal USP. The recommended dosage is listed in the package insert and prescribing information. It also provides a GTIN number and information on where to print medication guides. The medication is manufactured by Teva Pharmaceuticals in Israel and is distributed by Teva Pharmaceuticals in Parsippany, NJ. It includes cautions to keep the medication tightly closed and out of the reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.